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ABSTRACT - We analyzed computerized tomography (CT) findings in six patients with Fahr’s syndrome. They
presented calcifications in basal ganglia, dentate nucleus, subcortical region and semioval center, due to
alteration in calcium metabolism or due to senile relative hypoxemic state. The image pattern was not strict-
ly related with etiology, although some differences in dystrophic senile calcifications (the only one pres-
ent in semioval center and absent in subcortical region). CT is an easy exam, has maximum sensitivity and
allows diagnosis, contributing to early treatment of many etiologies of Fahr’s syndrome.
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Achados da tomografia computadorizada na síndrome de Fahr
RESUMO - Analisamos os achados de tomografia computadorizada (TC) de seis pacientes com síndrome de
Fahr. Eles apresentaram calcificações nos gânglios da base, núcleo denteado, região subcortical e centro
semi-oval, devidas a distúrbios no metabolismo do cálcio ou a estado de hipóxia relativa, por senilidade.
O padrão de imagem não apresenta relação clara com a etiologia, apesar de algumas diferenças no caso
das calcificações distróficas senis (as únicas presentes nos centros semi-ovais e ausentes na região subcor-
tical). TC é um exame de fácil realização, máxima sensibilidade e permite o diagnóstico, contribuindo para
o tratamento precoce de muitas das etiologias da síndrome de Fahr.
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Fahr’s disease refers to idiopathic calcification
of the basal ganglia. This condition has been known
since 1800s, many years before Fahr’s description,
in 1930, of a man with seizures and diffuse calcifi-
cations of the brain vessels and basal ganglia possi-
bly due to hypoparathyroidism1. So, Fahr’s disease
might be considered a misnomer2, because Fahr’s
report was not the first one and does not describe
idiopathic calcifications. Although this, the more
general term Fahr’s syndrome has been applied un-
til today to describe a variety of pathological situa-
tions of many etiologies, that occur with basal
ganglia calcification (BGC) without specific charac-
terization by neuroradiology.
Clinical features are important because BGC
may be viewed as an incidental finding. Headache,
vertigo, movement disorders, paresis, stroke like
events, cognitive impairment, psychiatric disor-
ders, pyramidal signals and seizures are the most
common manifestations3-6. Additionally, it has been
stated that “pathological calcifications” exist when
regions other than globus pallidus are involved7.
This study was carried out to correlate patholo-
gical BGC, dentate nucleus and subcortical calcifica-
tions on computerized tomography (CT) with disea-
se that caused them and to attempt to define sys-
temic metabolic mechanisms of calcification for-
mation.
METHOD
We selected and analyzed CT images of six patients
with BGC and dentate nucleus, subcortical region and
semioval center calcifications, performed with 2.5 mm
slice in skull base and 5 mm slice in cerebrum.
RESULTS
Table 1 summarizes clinical and radiological as-
pects of the six patients. One patient (with 65 years
old) did not present calcium serum alterations nei-
ther other associated disease. So, pathologic calci-
fications were attributed to senility. The five oth-
er patients presented disturbances in calcium me-
tabolism (correlated with primary hypoparathy-
roidism in two, AIDS in two, and panhypoptuita-
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rism secondary to Shehan’s syndrome in one). The
symptoms were variable as motor deficits, seizures,
comportment disturbances, headache and others.
All patients presented calcifications in globus palli-
dus, five (with calcium disturbances) in caudate, len-
tiform nucleus and subcortical region, two in den-
tate nucleus, one (with senile dystrophic calcifica-
tions) in semioval center, and one (with hypopara-
thyroidism) in thalamus (Fig 1).
DISCUSSION
We present patients with pathological BGC, den-
tate nucleus and white matter calcifications of dis-
tinct etiologies and clinical features. This kind of ab-
normality is related with many etiologies that can
be classified as inflammatory (CMV infection, neu-
rocysticercosis, toxoplasmosis, neurobrucellosis,
tuberculosis, HIV infection), tumoral (astrocytomas),
hypoxic and vascular (arteriovenous malforma-
tions calcified infarct, ischemic encephalophaty),
endocrine (hypoparathyroidsm, pseuso and pseudo-
hypoparathyroidism, hyperparathyroidism), toxic
(CO and Pb intoxication, hypervitaminosis D, radio-
therapy), metabolic and degenerative (senility, mi-
thocondrial encephalopaties, leukodistrophic disea-
ses, idiopathic familial, motor neuron disease, myo-
tonic muscular dystrophy, carbonic anidrase deficit,
biopterin deficit) and other (malabsorption, Down
syndrome, lupus, tuberous sclerosis, arthrogripo-
sis)8-13.
Except by familial cause, with unknown mecha-
nism, genetically determined, all other causes appear
to result of calcium deposits by serum abnormali-
ties (with a change in vascular permeability relat-
ed to local calcium concentration)14 or of dystroph-
ic calcifications, with physical abnormalities in small
vessel, focal circulatory disabilities and metabolic
disorders (hypoxia, hypoglycemia, and abnormal-
ities in the acid-base balance or electrolytes)15. Re-
duced blood flow to calcified regions is confirmed
in SPECT of the brain with 99mTc-hexamethhylpropi-
lenamine (99mTc-HMPAO)16.
We report patients with pathological calcifica-
tions attributed to different etiologies: dystroph-
ic (probable senile in one patient) and secondary
to abnormal calcium metabolism (in two patients
with hypoparathyroidsm). Both etiologies might be
associated in patients with AIDS (because abnor-
mal calcium levels are commonly associated with the
disease17 and because they presented hypoxic epi-
sodes caused by pulmonary disease) and in the pa-
tient with panhypopitutarism (secondary to abnor-
mal calcium levels and hypoglicemic crisis). The
only difference noted in the calcifications pattern
was their absence in subcortical region and basal
nucleus and their presence in semioval center, in the
patient with senile calcifications. Moreover, the pa-
tient with senile calcifications presented seizures
and headache. Usually, the dystrophic form is silent
or occur with extrapyramidal symptoms18. Since no
associated disease was identified as responsible
Table 1. Clinical and radiological aspects of patients.
Patient Sex Age Calcification site Associated disease Clinical findings
(years)
1 female 68 Lentiform nucleus, caudate Panhypoptuitarism secondary Hypoglicemic crisis
and subcortical to Shehan’s syndrome
2 female 23 Lentiform nucleus, caudate Primary hypoparathyroidism Complex partial seizures
and subcortical with secondary generaliza
tion, polineuropaty
3 female 65 Globus pallidus, semioval Anyone detected Headache and seizures
center and dentate nucleus
4 male 28 Lentiform nucleus, caudate, Primary hypoparathyroidism Fasciculations
subcortical, dentate nucleus
and thalamus
5 female 5 Lentiform nucleus, caudate HIV infection Alteration in behavior 
and subcortical (aggressively) and weakness
6 male 7 Lentiform nucleus, caudate HIV infection Global hypotonia without 
and subcortical choreo-athetotic movements
by these clinical features, in agreement with pre-
vious studies7 we suppose that dystrophic calcifica-
tions in other places than globus pallidus (for exam-
ple, dentate nucleus and semioval center as occurs
in this patient), are related to other symptoms in
adults (particularly to psychiatric disorders)19-21.
Because it involves many etiologies, it is diffi-
cult attribute neurological deficits as cause or con-
sequence of Fahr’s syndrome. Classical and recent
anatomical studies about the role of basal ganglia
in movement coordination22, subcortical region in
cognitive association and mood determination, and
hypoxia in epileptic activity23, points to correlation
between clinical features and calcifications site
and consequently hypoperfused area7,10.
Recognition of the intracranial calcifications in
Fahr’s syndrome has been made easier by the high
resolving capability of CT. Calcifications consist of
hydroxyapatite of a nature similar to that found
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in bones. Other elements include zinc, iron and
magnesium24. Because this material composition,
they are always hyperdense on CT. On magnetic re-
sonance imaging (MRI), however, their signal is va-
riable. On T1 weighted images, low signal is due
to the low proton density of calcium and other min-
eral ions present in higher concentration. Howe-
ver, they might present hyperintense signal, due
to proteins and mucopolysaccharides binding the
mineral ions. They might also to be undetected on
MRI when are in a intermediary stage25.
In conclusion, Fahr’s syndrome is manytimes a
treatable entity. Etiology is not directly correlat-
ed with image calcification pattern, except for so-
me differences noticed in calcifications site in
dystrophic senile ones. Topographic image studies
are promising to predict neurological deficits. Their
recognition by CT is easy, has maximum sensitivi-
ty and may be responsible by early treatment.
Fig 1. CT axial images show calcifications dentate nucleus and white matter of cerebellum (A), semioval center (B)
and globus pallidus (C) in 65 years old with senile dystrophic calcifications. Basal ganglia calcification (D) is found
in a patient with AIDS. Diffuse calcification in basal ganglia (E) and subcortical region (E and F) is shown in patients
with hipoparathyroidism and hypopituitarism, respectively. 
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